Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.

The post Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening. appeared on BitcoinEthereumNews.com.

Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech stocks…

Leave a Reply

Your email address will not be published. Required fields are marked *